CAH vs NMTC · P/E 35, rev $254.25B vs rev $2.0M
Cardinal Health Inc (CAH) versus Neuroone Medical Technologies Corp (NMTC) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Neuroone Medical Technologies Corp (NMTC) is a medical devices company listed on US.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported NMTC revenue for 2026-06-30 was $2.0M. Net income was -$2.0M. Revenue was down 17.5% from 2026-03-31 to 2026-06-30. NMTC currently screens at market cap $35.5M.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. NMTC currently screens at market cap $35.5M.
Not investment advice. Open the CAH and NMTC stock pages for the full models.
Not investment advice.